BIOMAT Database Logo BIOMAT Database Logo

[Treatment of delay of growth with anabolizing steroids]. 1970

M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet

UI MeSH Term Description Entries
D008297 Male Males
D009654 Norsteroids Steroids which have undergone contraction in ring size or reduction in side chains.
D005260 Female Females
D006128 Growth Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT.
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone

Related Publications

M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[Anabolizing steroids].
May 1958, Il Policlinico. Sezione pratica,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[Pharmacological basis of treatments with anabolizing steroids].
May 1971, Les Cahiers de medecine,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[Decrease of high density lipoproteins secondary to treatment with anabolizing steroids].
January 2007, Revista clinica espanola,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[Anabolizing steroids in pediatric therapy].
January 1971, Przeglad lekarski,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[Anti-infective action of anabolizing steroids].
January 1957, Lo sperimentale,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[The use of "anabolizing steroids" in children].
June 1962, La Semaine des hopitaux: therapeutique,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[Anabolizing steroids associated with insulin-glucose in the therapy of hyperazotemic states].
August 1968, La Clinica terapeutica,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[Effects of anabolizing 17 alkylating steroids in the treatment of various experimental hepatopathies. Morphological study].
October 1979, Revista clinica espanola,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[Further observations on the use of anabolizing steroids in chronic hyperazotemia].
January 1969, Minerva urologica,
M Albeaux-Fernet, and L Bellot, and L Canet, and J Deribreux, and M Gelinet
[The effects of anabolizing steroids on creatine metabolism in progressive muscular dystrophy].
June 1959, La Clinica pediatrica,
Copied contents to your clipboard!